A detailed history of Garrett Investment Advisors LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Garrett Investment Advisors LLC holds 9,780 shares of CRL stock, worth $1.82 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
9,780
Previous 9,290 5.27%
Holding current value
$1.82 Million
Previous $1.92 Million 0.36%
% of portfolio
0.21%
Previous 0.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$187.96 - $245.29 $92,100 - $120,192
490 Added 5.27%
9,780 $1.93 Million
Q2 2024

Jul 10, 2024

BUY
$206.39 - $268.73 $282,754 - $368,160
1,370 Added 17.3%
9,290 $1.92 Million
Q1 2024

Apr 12, 2024

BUY
$203.52 - $273.43 $180,522 - $242,532
887 Added 12.61%
7,920 $2.15 Million
Q4 2023

Jan 05, 2024

BUY
$164.52 - $238.84 $1.16 Million - $1.68 Million
7,033 New
7,033 $1.66 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.48B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Garrett Investment Advisors LLC Portfolio

Follow Garrett Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garrett Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garrett Investment Advisors LLC with notifications on news.